Search Results

No Results

    Recently Viewed

      Listening...

      Sorry, I don't understand. Please try again
      United States/Newsroom/Cardiovascular /New VOYAGER PAD Analysis Confirms Consistent Benefit of XARELTO® (rivaroxaban) Plus Aspirin Following Lower Extremity Revascularization (LER)
      Cardiovascular

      New VOYAGER PAD Analysis Confirms Consistent Benefit of XARELTO® (rivaroxaban) Plus Aspirin Following Lower Extremity Revascularization (LER)

      March 5, 2023
      1 min read

      Download the PDF